Simultaneous Screening and Quantitation of Amphetamines in Urine by On-line SPE-LC/MS Method

Amphetamines belong to stimulant drugs and are also controlled as illicit drugs worldwide. The conventional analytical procedure of amphetamines in human urine includes initial immunological screening followed by GCMS confirmation and quantitation. With new SAMHSA guidelines effective in Oct 2010, screening, confirmation and quantitation of illicit drugs including amphetamines were allowed to employ LC/MS and LC/MS/MS, which usually does not require a derivatization step as used in the GCMS method. The objective of this study was to develop an on-line SPE-LC/MS method for analysis of five amphetamines in urine without sample pre-treatment except dilution with water. The compounds studied include amphetamine (AMPH), methamphetamine (MAMP) and three newly added MDMA, MDA and MDEA by the new SAMHSA guideline. Four potential interferences and PMPA (R) as a control reference were also included to enhance the method reliability in identification of the five targeted amphetamines from those structurally similar analogues which potentially present in forensic samples.

*Not available in the U.S.

Content Type:
Paper
Document Number:
PO-CON1460E
Product Type:
Liquid Chromatograph-Mass Spectrometry, Mass Spectrometry
Keywords:
Amphetamines, human urine, Clinical research, Forensics, Healthcare, Pharmaceutical, Life Science, Forensics, Toxicology, Drug test, LCMS-2020
Language:
English
File Name:
apo114062.pdf
File Size:
455kb

View Article

For Research Use Only. Not for use in diagnostic procedures.

This page may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country.

Top of This Page

Please select your country or region.

Transferring to the local website of your country or region.

Transfer to
https://www.ssi.shimadzu.com/